UNLIMIT YOURSELF Are you up for a challenge?
Do you look for ways to grow in your job?
And do you want to build a remarkable career?
Then apply now!
We’re currently looking for :
Regional Head Regulatory & Scientific Affairs (RSA), EU With the following requirements :
Pharmacy, Biology, Clinical pharmacology).
A., Research & Development (R&D) in Neuchâtel, Switzerland. As a Regional Head RSA EU you will lead respective affiliates in the region and direct all activities related to the development and implementation of regulatory strategies for NGPs to obtain registration.
You will also provide direction to the Central Regulatory & Scientific Affairs function in order to establish registration requirements and define submission strategies, as well as work closely with Marketing and Sales to understand market prioritization for registration purposes.
Specific responsibilities :
NCPs and ensure on-going products compliance of the RRP portfolio marketed in the region
Here are 3 reasons PMI is the ultimate Employer :
1.We’re international :
you work with clients and learn on-the-job from team members from all over the world2.We’re flexible :
your work fits you and not the other way round, thanks to our Flexible Work Arrangement Program and3.We’re a certified top employer :
we consider our employees to be our strongest asset, and we are developing talent throughout all levels of the organization.
As the first multinational company in Switzerland to obtain the Equal-Salary label, for men and women, our competitive salary and compensation package is for all our employees.
JOIN A GLOBAL MARKET LEADER If you wish to contribute to the future of our business and to the new scientific journey of the industry, please apply online.
PMI is the world’s leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets.
In addition to the manufacture and sale of cigarettes, including the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of Reduced-Risk Products ( RRPs ).
RRPs is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking.
We have a range of RRPs in various stages of development, scientific assessment and commercialization.
Because our RRPs do not burn tobacco, they produce far lower quantities of harmful and potentially harmful compounds than found in cigarette smoke.